- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00233922
Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant
May 12, 2008 updated by: National University Hospital, Singapore
Patients with orbital injuries are entered into the trial.
Age: 20 - 70.
After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone.
Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months.
CT scan of the orbits are performed preop, 6 months & 12 months.
End point is the 12 month follow-up appointment.
Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients with orbital injuries are entered into the trial.
Age: 20 - 70.
After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone.
Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months.
CT scan of the orbits are performed preop, 6 months & 12 months.
End point is the 12 month follow-up appointment.
Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 119074
- National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age: 20 - 70 years facial trauma with orbital fractures
Exclusion Criteria:
- No other coexistent conditions eg. diabetes, heart disease, etc
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
visual acuity
|
Enophthalmos
|
Diplopia
|
Cosmetic appearance
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Thiam-Chye Lim, MBBS, FRCS, National University Hospital, Singapore
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2004
Study Completion (ACTUAL)
July 1, 2007
Study Registration Dates
First Submitted
October 5, 2005
First Submitted That Met QC Criteria
October 5, 2005
First Posted (ESTIMATE)
October 6, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
May 13, 2008
Last Update Submitted That Met QC Criteria
May 12, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NHG/RPR/04024
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orbital Fractures
-
Cairo UniversityRecruitingOrbital Fractures | Orbital Floor Fracture | Orbital Trauma | Blow-Out FracturesEgypt
-
Mohammed Ghassan Mohammed ShaalanEnrolling by invitationOrbital Floor (Blow-Out) Open Fracture | Enophthalmos TraumaticEgypt
-
Nahla Mahmoud AwadUnknown
-
AO Clinical Investigation and Publishing DocumentationCompletedOrbital Floor Fracture | Medial Orbital Wall FractureSingapore, United States, Germany, Spain
-
Cairo UniversityUnknownOrbital Fractures | Enophthalmos | Periorbital FractureEgypt
-
University of ArkansasWithdrawnOrbital Fractures | Orbital CellulitisUnited States
-
Hatem Adel AboelhassanRecruitingOrbital Neoplasms | Zygomatic Fractures | Maxillary Neoplasms | Orbital Bone Fracture | Maxillary Cyst | Facial DeformityEgypt
-
AZ Sint-Jan AVCompleted
-
University Hospital Inselspital, BerneInternational Bone Research AssociationCompleted
-
University of California, DavisCompletedOrbital Fractures
Clinical Trials on Osteosheet(r)
-
University of California, Los AngelesUniversity of Colorado, Denver; National Institute of Allergy and Infectious... and other collaboratorsCompletedRNA Virus Infections | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Respiratory Tract Disease | Virus Disease | Physiological Effects of Drugs | VaccinesUnited States
-
Klinikum NürnbergUnknown
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)CompletedRespiratory Tract Infections | Influenza | VaccinesUnited States
-
LifeScanCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedHealthy VolunteersFrance
-
Daping Hospital and the Research Institute of Surgery...Not yet recruiting
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)CompletedImmunization RatesUnited States
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)Completed